{"meta":{"query_hash":"e687f5624849","filters":{"venue":"Eurasian Journal of Medical Advances"},"cohort_total":1,"direct_labels_cover":0,"predictions_cover":1,"exported":1,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/e687f5624849","api":"https://metacan.xera.ac/api/v1/cohort?venue=Eurasian+Journal+of+Medical+Advances"},"results":[{"id":"W4389494173","doi":"10.14744/ejma.2023.94830","title":"Navigating Neurologic Adverse Events in Immune Checkpoint Inhibitor Therapy: Challenges and Strategies","year":2023,"lang":"en","type":"article","venue":"Eurasian Journal of Medical Advances","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"Adverse effect; Medicine; Immune system; Intensive care medicine; Immunology; Pharmacology","score_opus":0.03582005132380086,"score_gpt":0.34505268668252775,"score_spread":0.3092326353587269,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389494173","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0040635527,0.74565864,0.013863548,0.21317708,0.0048179114,0.00023652137,0.000302941,0.00037498088,0.017504828],"genre_scores_gemma":[0.075802684,0.7512222,0.0245115,0.1066903,0.03204224,0.00057590037,0.00075621525,0.0001648521,0.00823412],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979997,0.00075693865,0.00034460073,0.00027031772,0.00048741393,0.00014091696],"domain_scores_gemma":[0.98865485,0.0064169965,0.0014945441,0.00022176483,0.002273779,0.0009380032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0062164473,0.0009984463,0.0020288792,0.0013817627,0.0010106455,0.0031852394,0.0018659293,0.0024713485,0.0103091765],"category_scores_gemma":[0.0126949465,0.00023280288,0.0013442802,0.0006172983,0.00143063,0.0046655587,0.0021573112,0.006602989,0.0020268336],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034905423,0.00031953552,0.003981004,0.0036825133,0.00026796013,0.001083101,0.00023756463,0.0010335174,0.0007174652,0.017073885,0.123862654,0.84739184],"study_design_scores_gemma":[0.0004874815,0.0014894657,0.0060997666,0.026894433,0.0013044587,0.00819751,0.0015309802,0.0056225555,0.0013724762,0.075701214,0.87109226,0.00020745049],"about_ca_topic_score_codex":0.0022780772,"about_ca_topic_score_gemma":0.008373074,"teacher_disagreement_score":0.0103091765,"about_ca_system_score_codex":0.0020993743,"about_ca_system_score_gemma":0.0057958867,"threshold_uncertainty_score":0.034487665},"labels":[],"label_agreement":null}]}